共 37 条
- [1] Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adultsJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (03) : 494 - +Paller, Amy S.Tom, Wynnis L.Lebwohl, Mark G.Blumenthal, Robin L.Boguniewicz, MarkCall, Robert S.Eichenfield, Lawrence F.Forsha, Douglass W.Rees, William C.Simpson, Eric L.Spellman, Mary C.Gold, Linda F. SteinZaenglein, Andrea L.Hughes, Matilda H.Zane, Lee T.Hebert, Adelaide A.
- [2] Crisaborole Topical Ointment, 2%: A Nonsteroidal, Topical, Anti-Inflammatory Phosphodiesterase 4 Inhibitor in Clinical Development for the Treatment of Atopic DermatitisJOURNAL OF DRUGS IN DERMATOLOGY, 2016, 15 (04) : 390 - 396Jarnagin, KurtChanda, SanjayCoronado, DinaCiaravino, VicZane, Lee T.Guttman-Yassky, EmmaLebwohl, Mark G.
- [3] Phase 3 studies in atopic dermatitis with the novel, nonsteroidal topical phosphodiesterase 4 inhibitor, crisaboroleJOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S50 - S50Paller, A. S.Tom, W. L.Call, R. S.Eichenfield, L.Forsha, D.Rees, W. C.Zane, L. T.Hebert, A. A.
- [4] Long-term Safety of Crisaborole, a Novel, Nonsteroidal, Topical, Anti-inflammatory, Phosphodiesterase 4 Inhibitor in Children and Adults with Mild to Moderate Atopic DermatitisPEDIATRICS, 2018, 141Eichenfield, Lawrence F.Call, Robert S.Forsha, Douglass W.Fowler, JosephHebert, Adelaide A.Spellman, MaryGold, Linda F. SteinVan Syoc, MerrieZane, Lee T.Tschen, Eduardo
- [5] Efficacy and Safety of Crisaborole Topical Ointment, 2%, a Novel, Nonsteroidal, Topical, Anti-Inflammatory, Phosphodiesterase Inhibitor in 2 Phase 3 Studies in Children and Adults with Mild-to-Moderate Atopic DermatitisJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB397 - AB397Boguniewicz, MarkPaller, Amy S.Tom, Wynnis L.Lebwohl, Mark G.Blumenthal, Robin L.Call, Robert S.Eichenfield, Lawrence F.Forsha, Douglass W.Rees, William C.Simpson, Eric L.Gold, Linda F. SteinZaenglein, Andrea L.Hughes, Matty H.Zane, Lee T.Hebert, Adelaide A.
- [6] A Novel Nonsteroidal, Topical Anti-inflammatory, Phosphodiesterase 4 Inhibitor, Crisaborole Ointment, Reduced Pruritus and Signs of Atopic Dermatitis in 2 Phase 3 Studies in Children and AdultsPEDIATRICS, 2018, 141Hebert, Adelaide A.Eichenfield, Lawrence F.Lebwohl, Mark G.Paller, Amy S.Simpson, Eric L.Tom, Wynnis L.Hughes, Matilda H.Zane, Lee T.
- [7] Discovery of LEO 39652 a novel PDE4 inhibitor for topical treatment of atopic dermatitisJOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S115 - S115Larsen, J.Lambert, M.Nielsen, S. F.
- [8] Crisaborole Topical Ointment, 2%, a novel nonsteroidal, anti-inflammatory, topical, phosphodiesterase 4 inhibitor, reduced pruritus and signs of atopic dermatitis in 2 phase 3 studies in children and adults with mild-to-moderate atopic dermatitisJOURNAL OF IMMUNOLOGY, 2016, 196Zane, Lee ThomasHebert, Adelaide A.Eichenfield, Lawrence F.Lebwohl, Mark G.Paller, Amy S.Simpson, Eric L.Tom, Wynnis L.Hughes, Matty H.
- [9] Pharmacological activity of difamilast, a novel PDE4 inhibitor for the topical treatment of atopic dermatitis: Comparison with other PDE4 inhibitorsJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB255 - AB255Hiyama, HidetakaArichika, NaoyaSakurai, Kazushi
- [10] A novel, nonsteroidal, topical, anti-inflammatory, phosphodiesterase inhibitor, Crisaborole Topical Ointment, 2%, in two phase 3 studies in children and adults with mild to moderate atopic dermatitisJOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) : S166 - S166Paller, A. S.Tom, W. L.Call, R. S.Eichenfield, L.Forsha, D.Rees, W.Spellman, M.Zane, L. T.Hebert, A. A.